IMA Advisory Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22K Buy
153
+54
+55% +$729 ﹤0.01% 1074
2026
Q1
$1.37K Sell
99
-15
-13% -$209 ﹤0.01% 728
2025
Q4
$1.6K Buy
+114
New +$1.6K ﹤0.01% 709

Other funds holding RDY

IMA Advisory Services's RDY Position: Q2 2026 in Review

IMA Advisory Services increased its Dr. Reddy's Laboratories (RDY) stake by 55% in Q2 2026, buying an estimated $729 and bringing the position to 153 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

IMA Advisory Services first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • IMA Advisory Services held 153 shares of Dr. Reddy's Laboratories worth $2.22K as of Q2 2026.
  • IMA Advisory Services bought 54 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $729.
  • Dr. Reddy's Laboratories made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #1074 holding.
  • IMA Advisory Services first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.